Molecular diagnostic technologies for COVID-19: Limitations and challenges
Background: To curb the spread of the COVID-19 (coronavirus disease 2019) pandemic, the world needs diagnostic systems capable of rapid detection and quantification of the novel coronavirus (SARS-CoV-2). Many biomedical companies are rising to the challenge and developing COVID-19 diagnostics. In th...
Main Author: | Adeel Afzal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Journal of Advanced Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123220301788 |
Similar Items
-
Comparing lateral flow testing with a rapid RT‐PCR method for SARS‐CoV‐2 detection in the United Kingdom—A retrospective diagnostic accuracy study
by: Andrew Taylor, et al.
Published: (2022-09-01) -
Comparison of Two Different Commercial SARS-CoV-2 PCR Diagnostic Kits
by: Şebnem ŞENOL AKAR, et al.
Published: (2022-03-01) -
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories
by: Sibyle Etievant, et al.
Published: (2020-06-01) -
Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
by: Robert Kubina, et al.
Published: (2020-06-01) -
Clinical Evaluation of Three Commercial RT-PCR Kits for Routine COVID-19 Diagnosis
by: Rifat Tasnim Juthi, et al.
Published: (2022-11-01)